"Das Klinikum Landshut ist ein Krankenhaus der Schwerpunktversorgung mit 568 Planbetten / ‑plätzen, 20 Haupt- und Belegabteilungen, mehreren Tageskliniken sowie sieben Großgeräten. Als gemeinnützige GmbH in kommunaler Trägerschaft nehmen wir für das westliche Niederbayern und darüber hinaus einen überregionalen Versorgungsauftrag wahr. Wir sind Akademisches Lehrkrankenhaus der LMU München, überregionales Traumazentrum im Traumanetzwerk Ostbayern und verfügen über ein anerkanntes zertifiziertes onkologisches Zentrum, mehrere Organkrebszentren sowie über eine Pflegeschule."

During the past decade, Klinikum Landshut conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Landshut" #1 sponsor was "AGO Study Group" with 1 trials, followed by "AIO-Studien-gGmbH" with 1 trials sponsored, "Dominik Paul Modest" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "German CLL Study Group" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Landshut" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Crolll Gmbh" with 1 trials as a collaborator, "European Society of Intensive Care Medicine" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Landshut" are "Colorectal Cancer" (2 trials), "Breast Cancer" (1 trials), "Cholangiocarcinoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Circulating Tumor Cells" (1 trials). Many other conditions were trialed in "Klinikum Landshut" in a lesser frequency.

Most popular intervention types in "Klinikum Landshut" are "Drug" (12 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (2 trials), "Placebo" (2 trials), "5-FU and oxaliplatin" (1 trials), "Acalabrutinib" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Landshut" are 10 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Landshut". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Klinikum Landshut, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Landshut, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Klinikum Landshut has several departments that took part in Clinical trials: "Tagesklinik Landshut; Hämatologie/Onkologie" - 4 trials